Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

HIV latency in resting CD4+ T cell represents a key barrier preventing cure of the infection with antiretroviral drugs alone. Latency reversing agents (LRAs) can activate HIV expression in latently infected cells, potentially leading to their elimination through virus-mediated cytopathic effects, ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsden, Matthew D., Wu, Xiaomeng, Navab, Sara M., Loy, Brian A., Schrier, Adam J., DeChristopher, Brian A., Shimizu, Akira J., Hardman, Clayton T., Ho, Stephen, Ramirez, Christina M., Wender, Paul A., Zack, Jerome A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018613/
https://www.ncbi.nlm.nih.gov/pubmed/29800728
http://dx.doi.org/10.1016/j.virol.2018.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018613/
https://www.ncbi.nlm.nih.gov/pubmed/29800728
http://dx.doi.org/10.1016/j.virol.2018.05.006

Ejemplares similares